We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL
Automated ELISA-IFA-BLOT Processor AP 22
New
Gold Supplier
5-Part Automatic Hematology Analyzer
STEL5 PLUS
New
Reusable Readers
Lumos Reusable Readers
New
3-Part Diff Hematology Analyzer
HEMIX 3-60
Visit expo >

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Hematology

Image: The BD LSR Fortessa X-20 is a premium flow cytometer that brings endless possibilities to multicolor cell analysis (Photo courtesy of BD Biosciences)

Stem Cell Architecture Drives Myelodysplastic Syndrome Progression

Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible therapeutic approaches that target these cells. Their findings, which could have significant benefits for patients with disease progression, were published today in Nature Medicine. More...
10 May 2022
Image: Fluidigm CyTOF2 Mass Cytometer (Photo courtesy of University of Minnesota)

Epigenomic Biomarker Predict CAR T-Cell Therapy Resistance in Pediatric Leukemia

Children with acute lymphoblastic leukemia (ALL) whose cells express an epigenomic biomarker rooted in DNA methylation patterns may be less likely to respond to CD19-directed CAR T-cell therapy. More...
18 Apr 2022
Image: Umbilical cord blood has increased access to potentially curative therapy for patients with life-threatening disorders of the bone marrow and immune system (Photo courtesy of Cellsafe Biotech Group)

Primary Graft Failure Identified by Early Chimerism Following DCBU Transplantation

Umbilical cord blood transplantation (UCBT) has increased access to potentially curative therapy for patients with life-threatening disorders of the bone marrow and immune system. The introduction of reduced intensity conditioning (RIC) regimens and double umbilical cord unit infusions (DUCBT) has broadened the applicability of UCBT to frailer or larger recipients. More...
14 Apr 2022
Image: New data shows blood test highly accurate in detecting multiple cancers (Photo courtesy of Guardant Health)

Blood Test Proves Highly Accurate in Detecting Multiple Cancers in Early Stage

Guardant Health, Inc. (Redwood City, CA, USA) has announced new data demonstrating the ability of the company’s investigational next-generation Guardant SHIELD multi-cancer assay to accurately detect early-stage cancers. More...
13 Apr 2022
Image: LeukoPrint is a first-in-class leukemia sWGS CNA test (Photo courtesy of SeekIn Inc.)

First-of-Its-Kind Molecular Karyotyping Test Assists Hematologists in Diagnosing Leukemia

A new test kit can evaluate copy number aberrations (CNAs) in bone marrow cells and/or circulating cell-free DNA (cfDNA) via shallow whole-genome sequencing (sWGS), in combination with conventional cytogenetics technologies, to make leukemia diagnosis, molecular subtyping, prognostic stratification and treatment response monitoring more precise and comprehensive. More...
11 Apr 2022
Image: Antioxidant, inflammation levels may reveal new diagnostic tool for breast cancer (Photo courtesy of Pexels)

Blood Tests for Detecting Antioxidant and Inflammation Levels Could Diagnose Breast Cancer

Breast cancer is the most prevalent cancer in the world. Identifying new diagnostic techniques is of major importance to efforts that aim to minimize the disease’s devastating effects. Now, a new study that analyzes levels of antioxidants and stress markers in the blood could lead to a new diagnostic tool for breast cancer. More...
07 Apr 2022
Image: LyoPlas is freeze-dried plasma and combined packed red blood cells were compared to 0.9% saline for resuscitation of trauma-related hemorrhagic shock patients (Photo courtesy of DRK-Blutspendedienst West gGmbH)

Blood Products Use in Trauma-Related Hemorrhagic Shock Patients Questioned

Treatment of hemorrhagic shock is now increasingly focused on the early use of hemorrhage control, tranexamic acid, and blood-based resuscitation with packed red cells and plasma. The improved survival from these and other strategies within streamlined trauma systems have been reported in the military and civilian settings, and have stimulated an interest in prehospital transfusion. More...
05 Apr 2022


The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.
Copyright © 2000-2022 Globetech Media. All rights reserved.